ZLD 0.00% 37.0¢ zelira therapeutics limited

These compelling outcomes have now provided confidence for the...

  1. 1,028 Posts.
    lightbulb Created with Sketch. 175
    These compelling outcomes have now provided confidence for the company to evaluate the further progression of ZLT-L-007 into formal FDA clinical trials.“The results align perfectly with our strategy of generating scientifically rigorous and clinically validated data for our patent-protected proprietary cannabinoid-based drugs,” said Zelira CEO, Dr Oludare Odumosu.Additional insights from the full study will be reported, as they become available, during FY 23-23.

    An extract from the Australian

 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
0.000(0.00%)
Mkt cap ! $4.198M
Open High Low Value Volume
37.0¢ 38.0¢ 37.0¢ $6.724K 18.10K

Buyers (Bids)

No. Vol. Price($)
2 649 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 560 1
View Market Depth
Last trade - 15.31pm 21/06/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.